GOP Lawmakers Seize On Adverse Event Analysis, Push For Mifeprex Withdrawal
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Bartlett (R-Md.) is seeking to revitalize support for the “RU-486 Suspension & Review Act.”
You may also be interested in...
Mifeprex Post-Marketing Restriction Compliance To Be Questioned By Rep. Souder
Danco Labs declined to testify at a hearing on deaths associated with the use of the abortifacient mifepristone.
Mifeprex Post-Marketing Restriction Compliance To Be Questioned By Rep. Souder
Danco Labs declined to testify at a hearing on deaths associated with the use of the abortifacient mifepristone.
Mifeprex “Black Box” Warning Revised On Reports Of Sepsis Deaths
Four deaths have been reported in California patients undergoing a medical abortion with Mifeprex (RU-486). Patients did not present with the typical symptoms of infection; a “high index of suspicion” is needed to rule out sepsis, FDA says.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: